Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.04 USD | +2.90% | +7.86% | +5.17% |
Apr. 01 | Transcript : Yield10 Bioscience, Inc., Q4 2023 Earnings Call, Apr 01, 2024 | |
Apr. 01 | Yield10 Bioscience, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | 2.25M | Sales 2025 * | 4M | Capitalization | 3.88M |
---|---|---|---|---|---|
Net income 2024 * | -11M | Net income 2025 * | -13M | EV / Sales 2024 * | 1.72 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.97 x |
P/E ratio 2024 * |
-0.33
x | P/E ratio 2025 * |
-0.3
x | Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.41% |
Latest transcript on Yield10 Bioscience, Inc.
1 day | +2.90% | ||
1 week | +7.86% | ||
Current month | +6.68% | ||
1 month | -24.42% | ||
3 months | +1.44% | ||
6 months | +9.47% | ||
Current year | +5.17% |
Managers | Title | Age | Since |
---|---|---|---|
Oliver Peoples
FOU | Founder | 66 | 92-05-31 |
Charles Haaser
DFI | Director of Finance/CFO | 68 | 07-12-31 |
Kristi Snell
CTO | Chief Tech/Sci/R&D Officer | 56 | 96-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 67 | 06-09-30 | |
Richard Hamilton
BRD | Director/Board Member | 61 | 17-03-01 |
Oliver Peoples
FOU | Founder | 66 | 92-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 6.04 | +2.90% | 257,862 |
24-05-09 | 5.87 | +17.40% | 2,401,967 |
24-05-08 | 5 | +3.52% | 42,213 |
24-05-07 | 4.83 | -6.21% | 142,201 |
24-05-06 | 5.15 | -8.04% | 48,408 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.17% | 3.77M | |
+17.96% | 47.02B | |
+48.77% | 41.86B | |
+1.17% | 41.76B | |
-4.27% | 28.8B | |
+11.42% | 26.05B | |
-21.39% | 19.15B | |
+4.86% | 12.55B | |
+27.29% | 12.34B | |
-3.50% | 11.82B |
- Stock Market
- Equities
- YTEN Stock